Atlas Private Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,149
Closed -$416K 183
2025
Q2
$416K Sell
17,149
-16,303
-49% -$380K 0.05% 130
2025
Q1
$848K Sell
33,452
-24,881
-43% -$651K 0.12% 86
2024
Q4
$1.55M Sell
58,333
-7,863
-12% -$213K 0.22% 60
2024
Q3
$1.92M Buy
66,196
+1,730
+3% +$50.5K 0.28% 47
2024
Q2
$1.8M Buy
64,466
+34,142
+113% +$940K 0.29% 46
2024
Q1
$841K Sell
30,324
-24,065
-44% -$668K 0.28% 47
2023
Q4
$1.57M Sell
54,389
-3,780
-6% -$114K 0.29% 45
2023
Q3
$1.93M Buy
58,169
+4,951
+9% +$175K 0.36% 47
2023
Q2
$1.95M Buy
53,218
+28,826
+118% +$1.12M 0.4% 46
2023
Q1
$995K Buy
24,392
+210
+0.9% +$9.07K 0.46% 39
2022
Q4
$1.24M Sell
24,182
-370
-2% -$17.7K 0.66% 31
2022
Q3
$1.07M Sell
24,552
-641
-3% -$31.1K 0.65% 33
2022
Q2
$1.32M Sell
25,193
-3,629
-13% -$185K 0.79% 28
2022
Q1
$1.49M Buy
28,822
+585
+2% +$30.4K 0.66% 33
2021
Q4
$1.67M Sell
28,237
-800
-3% -$39.6K 0.77% 37
2021
Q3
$1.25M Buy
29,037
+1,830
+7% +$81.1K 0.65% 30
2021
Q2
$1.06M Buy
27,207
+556
+2% +$21.6K 0.58% 34
2021
Q1
$966K Buy
26,651
+6,223
+30% +$221K 0.54% 39
2020
Q4
$752K Buy
20,428
+1,324
+7% +$48.6K 0.5% 42
2020
Q3
$665K Buy
19,104
+1,454
+8% +$51K 0.56% 40
2020
Q2
$548K Buy
+17,650
New +$600K 0.49% 49

Other funds holding PFE

Atlas Private Wealth Advisors's PFE Position: Q3 2025 in Review

Atlas Private Wealth Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 17,149 shares — an estimated $416K sold.

Atlas Private Wealth Advisors first reported a position in PFE in Q2 2020 and held it in 21 quarters. The position peaked at $1.95M in Q2 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Atlas Private Wealth Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 17,149 Pfizer shares in Q3 2025, an estimated $416K.
  • Atlas Private Wealth Advisors first reported a position in Pfizer in Q2 2020 and held it in 21 quarters.
  • Atlas Private Wealth Advisors's Pfizer position peaked at $1.95M in Q2 2023.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Atlas Private Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.